Merck Indenture Agreements

16 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Indenture Agreement among MSD Netherlands Capital B.V., Merck & Co., Inc., and U.S. Bank Trust National Association (May 30, 2024)
Indenture Agreements
Merck
Pharmaceuticals
NY
2024
Merck & Co., Inc. 4.500% Notes Due 2033 Officers’ Certificate under Indenture with U.S. Bank Trust National Association
Indenture Agreements
Merck
Pharmaceuticals
2023
Merck & Co., Inc. Officers’ Certificate Establishing Terms of 2.450% Notes Due 2050 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2020
Merck & Co., Inc. Officers’ Certificate Establishing 4.000% Notes Due 2049 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2019
Third Supplemental Indenture among Merck Sharp & Dohme Corp., Schering Corporation, Merck & Co., Inc., and U.S. Bank Trust National Association, dated May 1, 2012
Indenture Agreements
Merck
Pharmaceuticals
2012
Merck & Co., Inc. 2.350% Notes Due 2022 Officers’ Certificate under Indenture
Indenture Agreements
Merck
Pharmaceuticals
NY
2015
Merck & Co., Inc. Officers’ Certificate for $1 Billion Floating Rate Notes Due 2018
Indenture Agreements
Merck
Pharmaceuticals
2013
Merck & Co., Inc. Officers’ Certificate for 1.300% Notes Due 2018 under Indenture
Indenture Agreements
Merck
Pharmaceuticals
2013
Indenture Agreement between Merck & Co., Inc. and U.S. Bank Trust National Association, dated January 6, 2010
Indenture Agreements
Merck
Pharmaceuticals
NY
2010
Fifth Supplemental Indenture among Merck & Co., Inc., Merck Sharp & Dohme Corp., and The Bank of New York Mellon, dated November 3, 2009
Indenture Agreements
Merck
Pharmaceuticals
2009
Second Supplemental Indenture among Merck Sharp & Dohme Corp., Merck & Co., Inc., and U.S. Bank Trust National Association, dated November 3, 2009
Indenture Agreements
Merck
Pharmaceuticals
2009
Fourth Supplemental Indenture between Schering-Plough Corporation and The Bank of New York (October 1, 2007)
Indenture Agreements
Merck
Pharmaceuticals
NY
2007
Third Supplemental Indenture between Schering-Plough Corporation and The Bank of New York (2017 and 2037 Senior Notes)
Indenture Agreements
Merck
Pharmaceuticals
NY
2007
Second Supplemental Indenture for $1,150,000,000 6.50% Senior Notes due 2033 between Schering-Plough Corporation and The Bank of New York
Indenture Agreements
Merck
Pharmaceuticals
NY
2003
First Supplemental Indenture for $1,250,000,000 5.30% Senior Notes due 2013 between Schering-Plough Corporation and The Bank of New York
Indenture Agreements
Merck
Pharmaceuticals
NY
2003
Indenture Agreement between Schering-Plough Corporation and The Bank of New York, dated November 26, 2003
Indenture Agreements
Merck
Pharmaceuticals
NY
2003